Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Study ID: NCT03219450
Start Date: 2021-08-18
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

NeoVax

Cyclophosphamide

Pembrolizumab

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Study ID: NCT05616650
Start Date: 2023-10-19
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

42

Intervention / Treatment

18F-DCFPyL

Stereotactic Body Radiation Therapy

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer

Study ID: NCT06356155
Start Date: 2025-07-22
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

Emportumab Vedotin

Pembrolizumab

Sponsor

University of Michigan Rogel Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

Study ID: NCT02422550
Start Date: 2015-04-09
End Date: 2026-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

567

Intervention / Treatment

MRI or CT

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

Study ID: NCT06145750
Start Date: 2023-10-31
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Ability to order FirstLook™

Continuing Medical Education for Lung Cancer

Sponsor

Delfi Diagnostics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Development and Analysis of a Stool Bank for Cancer Patients

Study ID: NCT04291755
Start Date: 2019-06-28
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Pembrolizumab Injection

Sponsor

Persephone Biosciences

Source: clinicaltrials.gov

Share:
Add to list

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Study ID: NCT06491238
Start Date: 2024-09-16
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Light Intensity Exercise

Moderate Intensity Exercise

Sponsor

HealthPartners Institute

Source: clinicaltrials.gov

Share:
Add to list

Intermittent Dosing of Dorsal Root Ganglion Stimulation As an Alternate Paradigm to Continuous Low-Frequency Therapy

Study ID: NCT04909138
Start Date: 2022-10-15
End Date: 2026-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

DRG stimulation 20 Hz 30/90

DRG stimulation 5 Hz 30/90

Sponsor

Rush University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Study ID: NCT05188508
Start Date: 2022-01-14
End Date: 2026-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

57

Intervention / Treatment

Pembrolizumab

Showcase and Tegosolomide

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Study ID: NCT06096038
Start Date: 2024-04-16
End Date: 2028-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

33

Intervention / Treatment

Cyclophosphamide

Fludarabine

Cell Therapy

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list